expHRD:一种基于转录组的个性化预测模型,用于对癌症同源重组缺陷评估
Jae Jun Lee1, Hyun Ju Kang2,3, Donghyo Kim4
1Computational Cancer Genomics Groups, Spanish Cancer Research Center (CNIO), Madrid, Spain.
BMC bioinformatics
|July 12, 2024
概括
这项研究介绍了expHRD,这是一种基于转录基因组的新方法,用于对同源重组缺陷 (HRD) 的评分. ExpHRD提供精确的定量HRD状态,克服了现有的基因组痕和RNA-seq方法的局限性,用于个性化癌症治疗决策.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 同源重组缺陷 (HRD) 是预测对化疗和PARP抑制剂反应的关键生物标志物.
- 目前的HRD评估依赖于BRCA1/2突变或基因组痕 (scarHRD),由于缺少生殖系数据而存在局限性.
- 现有的RNA-seq方法主要提供队列级分类,缺乏定量HRD指标.
研究的目的:
- 引入expHRD,一种基于转录基因的新型框架,用于定量,n-of-1 HRD评分.
- 利用基因表达数据开发一种精确的HRD预测方法.
- 解决当前HRD评估方法的局限性,特别是在基因组数据有限的场景中.
主要方法:
- 在癌症基因组图谱 (TCGA) 全癌症训练集上使用弹性净回归开发了一个预测模型.
- 使用引导技术来导出HRD基因组用于expHRD计算.
- 在卵巢癌数据集 (TCGA-OV和GDC) 中通过内部和外部队列评估验证了expHRD方法.
主要成果:
- 在expHRD方法证明了与scarHRD显著的相关性.
- 与现有方法相比,ExpHRD在识别HRD高样本方面表现出卓越的表现.
- 在独立的卵巢癌队列中证实了临床可行性.
结论:
- 该expHRD方法使用转录组数据准确预测HRD状态.
- 这种新的方法克服了数据的局限性,并增强了转录组学在个性化癌症治疗中的临床实用性.
- ExpHRD提供精确,定量的人力资源发展得分,为改善各种恶性瘤的临床决策铺平了道路.
更多相关视频
相关概念视频
Homologous Recombination
50.4K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.4K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Crossing Over
4.3K
Crossing over is the exchange of genetic information between homologous chromosomes during prophase I of meiosis I. Genetic recombination gives rise to allelic diversity in the newly formed daughter cells. In humans, crossing over produces genetically distinct haploid egg and sperm cells that undergo fertilization to produce unique offspring. Before cell division starts, the germ cell’s chromosome(s) undergo duplication in the S phase of the cell cycle. As the cells enter prophase I,...
4.3K
Conservative Site-specific Recombination and Phase Variation
6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.0K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K


